Abstract
A fifth-generation model for receptor/gene-mediated corticosteroid effects was proposed based on results from a 50 mg/kg IV bolus dose of methylprednisolone (MPL) in male adrenalectomized rats, and confirmed using data from other acute dosage regimens. Steady-state equations for receptor down-regulation and tyrosine aminotransferase (TAT) enzyme induction patterns were derived. Five groups of male Wistar rats (n=5/group) were subcutaneously implanted with Alzet mini-pumps primed to release saline or 0.05, 0.1, 0.2, and 0.3 mg/kg/hr of MPL for 7 days. Rats were sacrificed at the end of the infusion. Plasma MPL concentrations, blood lymphocyte counts, and hepatic cytosolic free receptor density, receptor mRNA, TAT mRNA, and TAT enzyme levels were quantitated. The pronounced steroid effects were evidenced by marked losses in body weights and changes in organ weights. All four treatments caused a dose-dependent reduction in hepatic receptor levels, which correlated with the induction of TAT mRNA and TAT enzyme levels. The 7 day receptor mRNA and free receptor density correlated well with the model predicted steady-state levels. However, the extent of enzyme induction was markedly higher than that predicted by the model suggesting that the usual receptor/gene-mediated effects observed upon single/intermittent dosing of MPL may be countered by alterations in other aspects of the system. A mean IC50 of 6.1 ng/mL was estimated for the immunosuppressive effects of methylprednisolone on blood lymphocytes. The extent and duration of steroid exposure play a critical role in mediating steroid effects and advanced PK/PD models provide unique insights into controlling factors.
Similar content being viewed by others
REFERENCES
R. F. van Vollenhoven. Corticosteroids in rheumatic disease. Understanding their effects is key to their use. Postgrad. Med. 103:137–142(1998).
R. P. Kimberly. Treatment. Corticosteroids and anti-inflammatory drugs. Rheum. Dis. Clin. North Am. 14:203–221(1988).
H. A. Boushey. Effects of inhaled corticosteroids on the consequences of asthma. J. Allergy Clin Immunol. 102:S5–16 (1998).
W. J. Jusko. Receptor-mediated pharmacodynamics of corticosteroids. Prog. Clin. Biol. Res. 387:261–270(1994).
C. A. Dujovne and D. L. Azarnoff. Clinical complications of corticosteroid therapy. A selected review. Med. Clin. North Am. 57:1331–1342(1973).
D. B. Haughey and W. J. Jusko. Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation. J. Pharmacokinet. Biopharm. 20:333–355 (1992).
Z. X. Xu, Y. N. Sun, D. C. DuBois, R. R. Almon, and W. J. Jusko. Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver. J. Pharmacokinet. Biopharm. 23:163–181 (1995).
Y. N. Sun, D. C. DuBois, R. R. Almon, and W. J. Jusko. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor_ gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J. Pharmacokinet. Biopharm. 26:289–317(1998).
Y. N. Sun, D. C. DuBois, R. R. Almon, N. A. Pyszczynski, and W. J. Jusko. Dosedependence and repeated-dose studies for receptor_gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J. Pharmacokinet. Biopharm. 26:619–648(1998).
R. Shiman and D. W. Gray. Formation and fate of tyrosine. Intracellular partitioning of newly synthesized tyrosine in mammalian liver. J. Biol. Chem. 273:34760–34769. (1998).
J. M. Dhahbi, P. L. Mote, J. Wingo, J. B. Tillman, R. L. Walford, and S. R. Spindler. Calories and aging alter gene expression for gluconeogenic, glycolytic, and nitrogen-metabolizing enzymes. Am. J. Physiol. 277:E352–360. (1999).
B. I. Labow, W. W. Souba, and S. F. Abcouwer. Glutamine synthetase expression in muscle is regulated by transcriptional and posttranscriptional mechanisms. Am. J. Physiol. 276:E1136–1145. (1999).
B. I. Labow, S. F. Abcouwer, C. M. Lin, and W. W. Souba. Glutamine synthetase expression in rat lung is regulated by protein stability. Am. J. Physiol. 275:L877–886. (1998).
W. F. Ebling, S. J. Szefler, and W. J. Jusko. Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man. Drug Metab. Dispos. 13:296–304. (1985).
F. D. Boudinot, R. D'Ambrosio, and W. J. Jusko. Receptor-mediated pharmacodynamics of prednisolone in the rat. J. Pharmacokinet. Biopharm. 14:469–493. (1986).
D. C. DuBois, R. R. Almon, and W. J. Jusko. Molar quantification of specific messenger ribonucleic acid expression in northern hybridization using cRNA standards. Anal. Biochem. 210:140–144. (1993).
D. C. DuBois, Z. X. Xu, L. McKay, R. R. Almon, N. Pyszcznski, and W. J. Jusko. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment. J. Steroid Biochem. Mol. Biol. 54:237–243. (1995).
T. I. Diamondstone. Assay of tyrosine transaminase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenzaldehye. Anal. Bichem. 16:395–401(1966).
O. M. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–272(1951).
R. H. Oakley and J. A. Cidlowski. Homologous down regulation of the glucocorticoid receptor: the molecular machinery. Crit. Reû. Eukaryot. Gene Expr. 3:63–88(1993).
J. A. Schlechte, B. H. Ginsberg, and B. M. Sherman. Regulation of the glucocorticoid receptor in human lymphocytes. J. Steroid Biochem. 16:69–74. (1982).
G. F. Shipman, C. D. Bloomfield, K. J. Gajl-Peczalska, A. U. Munck, and K. A. Smith. Glucocorticoids and lymphocytes. III. Effects of glucocorticoid administration on lymphocyte glucocorticoid receptors. Blood 61:1086–1090. (1983).
Y. Dong, L. Poellinger, J. A. Gustafsson, and S. Okret. Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranslational mechanism. Mol. Endocrinol. 2:1256–1264(1988).
W. V. Vedeckis, M. Ali, and H. R. Allen. Regulation of glucocorticoid receptor protein and mRNA levels. Cancer Res. (Suppl.). 49:2295s–2320s(1989).
D. Z. D'Argenio and A. Schumitzky. ADAPT II User's Guide: Pharmacokinetic_Pharmacodynamic Systems Analysis Software. Biomedical Simulations Resource, Los Angeles, CA (1997).
D. K. Granner, E. B. Thompson, and G. M. Tomkins. Dexamethasone phosphate-induced synthesis of tyrosine aminotransferase in hepatoma tissue culture cells. Studies of the early phases of induction and of the steroid requirement for maintenance of the induced rate of synthesis. J. Biol. Chem. 245:1472–1478(1970).
E. Schmid, W. Schmid, M. Jantzen, D. Mayer, B. Jastorff, and G. Schutz. Transcription activation of the tyrosine aminotransferase gene by glucocorticoids and cAMP in primary hepatocytes. Eur. J. Biochem. 165:499–506(1987).
T. Noguchi, M. Diesterhaft, and D. Granner. Dibutyryl cyclic AMP increases the amount of functional messenger RNA coding for tyrosine aminotransferase in rat liver. J. Biol. Chem. 253:1332–1335(1978).
S. Hashimoto, W. Schmid, and G. Schutz. Transcriptional activation of the rat liver tyrosine aminotransferase gene by cAMP. Proc. Natl. Acad. Sci. U.S.A. 81:6637–6641. (1984).
K. L. Lee, P. L. Darke, and F. T. Kenney. Role of coenzyme in aminotransferase turnover. J. Biol. Chem. 252:4958–4961(1977).
P. Hogger and P. Rohdewald. Glucocorticoid receptors and fluticasone propionate. Reû. Contemp. Pharmacother. 9:501–522(1998).
R. Djordjevic-Markovic, O. Radic, V. Jelic, M. Radojcic, V. Rapic-Otrin, S. Ruzdijic, M. Krstic-Demonacos, S. Kanazir, and D. Kanazir. Glucocorticoid receptors in ageing rats. Exp. Gerontol. 34:971–982. (1999).
C. M. Silva, F. E. Powell-Oliver, C. M. Jewell, M. Sar, V. E. Allgood, and J. A. Cidlowski. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 59:436–442(1994).
F. Svec and M. Rudis. Dissociation between the magnitude of nuclear binding and the biopotency of glucocorticoids. Endocrinology 111:699–702. (1982).
R. I. Salganik, N. P. Mertvetsov, and S. V. Argutinskaya. The patterns of RNA synthesis and induction of glycogenic enzymes in rat liver under continuous cortisol administration. J. Steroid Biochem. 3:791–797(1972).
R. Ramakrishnan, D. C. DuBois, R. R. Almon, N. A. Pyszczynski, and W. J. Jusko. Pharmacodynamics and pharmacogenomics of methylprednisolone during seven-day infusions in rats. J. Pharmacol Exp. Ther. 300:245–256(2002).
J. D. Baxter and P. H. Forsham. Tissue effects of glucocorticoids. Am. J. Med. 53:573–589 (1972).
M. Sparberg, A. Gottschalk, and J. B. Kirsner. Liver abscess complication regional enteritis: report of two cases. Gastroenterology 49:548–551(1965).
R. B. Hill. Production of fatty liver in the rat by cortisone. Proc. Soc. Exp. Biol. 114:766 (1963).
J. P. Jones, Jr., E. P. Engleman, and J. S. Najarian. Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N. Engl. J. Med. 273:1453–1458 (1965).
M. Alexandrova, D. Mascuchova, and P. Tatar. Comparison of the biopotency of corticosterone and dexamethasone acetate in glucocorticoid receptor down regulation in rat liver. J. Steroid Biochem. 32:531–535. (1989).
A. N. D'Agostino and M. Chiga. Cortisone myopathy in rabbits. A light and electron microscopic study. Neurology 16:257–263. (1966).
A. N. D'Agostino and M. Chiga. Morphologic changes in cardiac and skeletal muscle induced by corticosteroids. Ann. N.Y. Acad. Sci. 138:73–81(1966).
D. S. David, M. H. Grieco, and P. Cushman, Jr. Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. J. Chronic Dis. 22:637–711(1970).
J. J. Christian. ACTH-induced renal glomerular disease in intact, adrenalectomized and castrated male mice. Proc. Soc. Exp. Biol. Med. 126:152–157(1967).
G. M. Ferron, N. A. Pyszczynski, and W. J. Jusko. Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats. J. Pharmacokinet. Biopharm. 27:1–21. (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ramakrishnan, R., DuBois, D.C., Almon, R.R. et al. Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats. J Pharmacokinet Pharmacodyn 29, 1–24 (2002). https://doi.org/10.1023/A:1015765201129
Issue Date:
DOI: https://doi.org/10.1023/A:1015765201129